[Angiotensin converting enzyme inhibitors and respiratory system].
Angiotensin converting enzyme inhibitors (ACE-I) are generally-applied medicaments in treatment and prevention of many illnesses. Although they are generally well-tolerated by an organism, their application might cause side-effects in a respiratory system, such as: dry cough, angioedema. They can also cause or strengthen bronchospasm. In this paper we analyse mechanism responsible for ACE-I side-effects concerning the respiratory system. The paper also highlights a positive effects of lung fibrosis and reduction of pneumonia risk in elderly people.
Serafin-Bromblik
Jolanta
J
Slaska Akademia Medyczna w Katowicach, Katedra i Oddział Kliniczny Chorób Wewnetrznych w Tychach. klinwewtychy@poczta.onet.pl
Bartula
Monika
M
Marcisz
Czesław
C
D000328:Adult; D000368:Aged; D000799:Angioedema / Q000139:chemically induced* / Q000503:physiopathology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D001986:Bronchial Spasm / Q000139:chemically induced*; D003371:Cough / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D011658:Pulmonary Fibrosis / Q000517:prevention & control*; D012137:Respiratory System / Q000503:physiopathology*
D000806:Angiotensin-Converting Enzyme Inhibitors